Souhaitez-vous accéder aux communiqués récents ?

Oslo, Norway, 24 June 2020 Vistin Pharma ASA (OSE: VISTIN), please find attached the minutes from the extraordinary general meeting held on 24 June 2020. All matters were resolved as proposed in the...

Oslo, Norway, 17 June 2020 Vistin Pharma ASA (OSE: VISTIN), as previously announced Vistin Pharma ASA will be conducting the Extraordinary General Meeting on the 24 of June as a digital meeting,...

Oslo, Norway, 03 June 2020 Vistin Pharma ASA (OSE: VISTIN), please find attached the call for an Extraordinary General Meeting in Vistin Pharma, to be held on 24 June at 13:00 CEST. Due to the...

Andreas Bryn Bakkerud, Controller of Vistin Pharma ASA, and a primary insider, has on 03 June 2020 purchased 7 500 shares in Vistin Pharma ASA at an average price of NOK 11.35 per share. Following...

Ole Enger, Chairman of the Board of Vistin Pharma ASA, and a primary insider, has on Friday 29th of May 2020 sold 141 471 shares in Vistin Pharma ASA at an average price of NOK 12.12 per share....

Please find attached the Independent Auditor's Report for 2019 for Vistin Pharma ASA. The whole set of documents in relation to the 2019 annual report is available on www.vistin.com. ***** For...

Magnus Tolleshaug, Commercial Director of Vistin Pharma ASA, and a primary insider, has on 22 May 2020 purchased 10 000 shares in Vistin Pharma ASA at an average price of NOK 12.83 per share....

The shares in Vistin Pharma ASA will be traded ex dividend NOK 1 as from today, 20. May 2020. ...

Oslo, Norway, 19 May 2020 Vistin Pharma ASA (OSE: VISTIN), please find attached the minutes from the Annual General Meeting held on 19 May 2020. All matters were resolved as proposed in the call...

Oslo, Norway, 12 May 2020 Vistin Pharma ASA (OSE: VISTIN), as previously announced Vistin Pharma ASA will be conducting this year's Annual General Meeting on the 19 of May as a digital meeting,...